Andrew Saik
Chief Financial Officer; Director · 5 filings · Latest: Jun 24, 2026
ARVINAS, INC.
Milestone Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARVN | Andrew Saik | Chief Financial Officer | Jun 24, 2026 | Sale | $8.16 | 5,696 | $46.5K | 187,432 | |
ARVN | Andrew Saik | — | Jun 24, 2026 | Proposed Sale | $8.14 | 5,846 | $47.6K | — | |
ARVN | Andrew Saik | Chief Financial Officer | May 11, 2026 | Sale | $9.94 | 11,139 | $110.7K | 193,128 | |
ARVN | Andrew Saik | — | May 11, 2026 | Proposed Sale | $10.11 | 11,343 | $114.7K | — | |
ARVN | Andrew Saik | Chief Financial Officer | Feb 13, 2026 | Sale | $11.89 | 5,134 | $61.0K | 159,267 | |
ARVN | Andrew Saik | — | Feb 13, 2026 | Proposed Sale | $11.89 | 5,134 | $61.1K | — | |
ARVN | Andrew Saik | — | Jun 24, 2025 | Proposed Sale | $7.35 | 5,927 | $43.6K | — |